Genus plc

Genus plc
Type	Public
Traded as	LSE: GNS; FTSE 250 component;
ISIN	GB0002074580
Industry	Biotechnology
Founded	1933
Headquarters	Basingstoke, Hampshire, UK
Key people	Iain Ferguson, Chairman; Jorgen Kokke, CEO
Revenue	£658.1 million (2026)
Operating income	£87.3 million (2026)
Net income	£285.5 million (2026)
Website	www.genusplc.com

Genus plc is a British-based business selling elite genetics and other products manufactured using biotechnology to cattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.

History

The business has its origins in the former Breeding & Production Division of the Milk Marketing Board which was established in 1933 and broken up in 1994.^[3] In 1999 Genus acquired ABS Global, a company founded by J.R. Prentice in the US as the American Breeders Service in 1941 selling the semen of cattle.^[4] In 2005 Genus acquired, through the takeover of Sygen International plc, PIC, a company founded by six pork producers in the UK as the Pig Improvement Company in 1962.^[5]

Operations

The company has three divisions:^[6]

ABS - products for cattle
PIC - products for pigs
Genus R&D - management of the research and development pipeline for cattle, pigs and other species.

PIC's pedigree herds sire an estimated 30% of commercially reared pigs.^[7]

References

1 2 "About Us - Our Team". Genus plc. Retrieved 2 August 2023.
1 2 3 "Annual Results for the year ended 30 June 2026" (PDF). Genus plc. Retrieved 11 September 2026.
↑ The BSE Inquiry Archived 2008-10-10 at the Wayback Machine
↑ "Genus agrees to acquire ABS Global". Milwaukee Business Journal. 3 August 1999. Retrieved 1 March 2020.
↑ "Genus Completes Acquisition Of Sygen". The Pig Site. Archived from the original on 9 February 2012. Retrieved 28 March 2015.
↑ "Genus". Market Watch. Retrieved 25 March 2018.
↑ Devlin, Hannah (20 June 2018). "Scientists genetically engineer pigs immune to costly disease". The Guardian. Retrieved 11 December 2021.

External links

Official site

[board-1] 1 2 "About Us - Our Team". Genus plc. Retrieved 2 August 2023.

[results-2] 1 2 3 "Annual Results for the year ended 30 June 2026" (PDF). Genus plc. Retrieved 11 September 2026.

[3] The BSE Inquiry Archived 2008-10-10 at the Wayback Machine

[4] "Genus agrees to acquire ABS Global". Milwaukee Business Journal. 3 August 1999. Retrieved 1 March 2020.

[5] "Genus Completes Acquisition Of Sygen". The Pig Site. Archived from the original on 9 February 2012. Retrieved 28 March 2015.

[6] "Genus". Market Watch. Retrieved 25 March 2018.

[Devlin_2018-7] Devlin, Hannah (20 June 2018). "Scientists genetically engineer pigs immune to costly disease". The Guardian. Retrieved 11 December 2021.

[1]

[2]

[3]

[4]

[5]

[6]

[7]